U.S. flag

An official website of the United States government

PMC Full-Text Search Results

Items: 3

1.
FIG. 3.

FIG. 3. From: Gastric Bypass Surgery Enhances Glucagon-Like Peptide 1–Stimulated Postprandial Insulin Secretion in Humans.

Glucagon (A), GLP-1 (B), and GIP (C) response to meal ingestion during hyperglycemic clamp with and without Ex-9 infusion (saline: solid line, Ex-9: dashed line) in the three study groups. Data are presented as means ± SEM.

Marzieh Salehi, et al. Diabetes. 2011 Sep;60(9):2308-2314.
2.
FIG. 2.

FIG. 2. From: Gastric Bypass Surgery Enhances Glucagon-Like Peptide 1–Stimulated Postprandial Insulin Secretion in Humans.

Blood glucose levels and insulin response during oral-IV hyperglycemic clamp with Ex-9 (dashed line, open symbols) or saline infusion (solid line, closed symbols) in Asym-GB (left), Hypo-GB (middle), and nonsurgical control subjects (right). Blood glucose (A), insulin (B), and insulin secretion rates (C) are shown. Data are presented as means ± SEM.

Marzieh Salehi, et al. Diabetes. 2011 Sep;60(9):2308-2314.
3.
FIG. 1.

FIG. 1. From: Gastric Bypass Surgery Enhances Glucagon-Like Peptide 1–Stimulated Postprandial Insulin Secretion in Humans.

Blood glucose (C), insulin (B), and insulin secretion rate (A) in response to liquid meal ingestion at screening visit of Asym-GB (n = 12, solid line, closed symbols) vs. Hypo-GB (n = 11, dashed line, open symbols). Data are shown for the number of subjects at any given time as means ± SEM (only 2 of 11 subjects from Hypo-GB group completed the study).

Marzieh Salehi, et al. Diabetes. 2011 Sep;60(9):2308-2314.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center